[go: up one dir, main page]

TN2013000161A1 - Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate - Google Patents

Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate

Info

Publication number
TN2013000161A1
TN2013000161A1 TNP2013000161A TN2013000161A TN2013000161A1 TN 2013000161 A1 TN2013000161 A1 TN 2013000161A1 TN P2013000161 A TNP2013000161 A TN P2013000161A TN 2013000161 A TN2013000161 A TN 2013000161A TN 2013000161 A1 TN2013000161 A1 TN 2013000161A1
Authority
TN
Tunisia
Prior art keywords
oxobutyl
pyrimidin
tartrate
hydrate
trifluoromethyl
Prior art date
Application number
TNP2013000161A
Other languages
French (fr)
Inventor
Ki Sook Park
Jung Min Yun
Bong Chan Kim
Kyu Young Kim
Ji Hye Lee
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/KR2011/008186 external-priority patent/WO2012060590A2/en
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of TN2013000161A1 publication Critical patent/TN2013000161A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to 1.5 hydrate of of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoropiperidin-2-one tartrate, a process for preparing the same, and a pharmaceutical composition for inhibiting DPP-IV, which comprises said compound as the active component.
TNP2013000161A 2011-10-31 2013-04-12 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate TN2013000161A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2011/008186 WO2012060590A2 (en) 2010-11-01 2011-10-31 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate

Publications (1)

Publication Number Publication Date
TN2013000161A1 true TN2013000161A1 (en) 2014-11-10

Family

ID=54360602

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000161A TN2013000161A1 (en) 2011-10-31 2013-04-12 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate

Country Status (1)

Country Link
TN (1) TN2013000161A1 (en)

Similar Documents

Publication Publication Date Title
PH12013500685A1 (en) Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
MX356401B (en) Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (trk) inhibitors.
JO3111B1 (en) Substituted triazolopyridines and their use as ttk inhibitors
MX2013011854A (en) Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent.
WO2010092090A3 (en) Novel salts of sitagliptin
UA108926C2 (en) LibreOfficeKINASE PYRROLO[2,3-DEPENDENT INHIBITORS
MD20140072A2 (en) New pyrrole compounds, process for their preparation and pharmaceutical compositions containing them
PH12013502169A1 (en) Triazolopyridines
MX2013005445A (en) Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors.
WO2012007345A3 (en) Substituted imidazo[1,2-a]pyrimidines and -pyridines
PH12014501258A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
MX340574B (en) Imidazo pyrazines.
EA029539B8 (en) Pharmaceutical composition of sitagliptin
JO3249B1 (en) Aza-di-cyclic di-aryl ether salts and methods of making primers thereof
TN2013000161A1 (en) Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
WO2012136356A8 (en) 6,7-diydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
TN2013000014A1 (en) Anticancer derivatives, preparation thereof and therapeutic use thereof
TN2013000426A1 (en) Triazolopyridines
GB201107755D0 (en) Novel compounds
CL2012001112A1 (en) Heteroaryl derived compounds, jak3 kinase inhibitors; pharmaceutical composition comprising them; Preparation process; Useful in the treatment of immune diseases, transplant rejection, autoimmune, inflammatory diseases such as arthritis.